A  Phenomenelle Angels Fund


     Office Locations:

University Research Park
510 Charmany, Suite 175B
Madison, WI 53719
Phone: 608-441-8315



  • Seed



  • Communications & Networking
  • Consumer Products & Services
  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare



    Phenomenelle Angels Fund I, LP is an early stage fund that invests in women and minority owned or managed businesses in Wisconsin and the Midwest. Qualifying businesses must have at least one woman or an ethnic minority holding substantial ownership or in an executive (C-level) position. Phenomenelle invests in exceptional management teams that exploit proprietary technology to create breakthrough applications in the following market sectors: Information Technology, BioTechnology/Life Sciences, Clean Technology, Consumer Goods/Services and Communications. The group targets companies that have, or will be on, a runrate of $1 million or more in revenues, with plans to grow to $20 million or more within 5 years. Phenomenelle's investments will typically be in the $100,000 to $500,000 range, with a reserve for follow-on investments.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dedee Wojtal Managing Director
    Joseph P. Hildebrandt Managing Director
    Lauren Flanagan Managing Director
    Tiffany Wilke Principal
    Valerie H. Wulf Principal


    Portfolio companies include:

      EraGen BioSciences
        web link

        web link

        web link

        web link

        web link

      Stemina Biomarker Discovery
        web link

      Third Solutions
        web link

      TrafficCast International
        web link


    Recent News: